{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"84"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}],"units":"Participants"}],"description":"Non-relapse mortality (NRM) is defined as death from any cause other than relapse disease. Bayesian monitoring scheme described in Thall, Simon, and Estey (1996) employed to perform interim monitoring of the data during the course of the trial separately within each group.","groups":[{"description":"Patients that received a transplant from a haploidentical donor","id":"OG000","title":"Haplo Arm"},{"description":"Patients that received a transplant from a 1 antigen mismatched related or unrelated donor","id":"OG001","title":"1AgMM Related/Unrelated Donors"},{"description":"Patients that received a transplant from a matched unrelated donor","id":"OG002","title":"MUD Donor"},{"description":"Patients receiving a second transplant","id":"OG003","title":"Second Transplant"},{"description":"Patients with the diagnosis of Myelofibrosis","id":"OG004","title":"Myelofibrosis"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Second Transplant and Myelofibrosis was not evaluated due to low accrual.","reportingStatus":"POSTED","timeFrame":"At 100 days","title":"Number of Participants With Non-relapse Mortality (NRM)","type":"PRIMARY","unitOfMeasure":"Participants"}